Prudential PLC lessened its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 94.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 366 shares of the medical instruments supplier’s stock after selling 6,542 shares during the quarter. Prudential PLC’s holdings in Mettler-Toledo International were worth $510,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Mettler-Toledo International by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after purchasing an additional 34,466 shares during the last quarter. Capital International Investors boosted its stake in Mettler-Toledo International by 1.2% during the third quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock worth $1,055,203,000 after buying an additional 10,395 shares during the last quarter. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 10.7% during the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after buying an additional 76,478 shares during the last quarter. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after buying an additional 14,106 shares during the last quarter. Finally, Norges Bank acquired a new position in Mettler-Toledo International during the fourth quarter worth $520,989,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the company. Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Barclays lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Finally, Citigroup lowered their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average price target of $1,408.55.
Mettler-Toledo International Stock Down 1.3%
Shares of Mettler-Toledo International stock opened at $1,139.04 on Tuesday. Mettler-Toledo International, Inc. has a 52 week low of $1,023.05 and a 52 week high of $1,525.17. The business’s fifty day simple moving average is $1,212.95 and its 200-day simple moving average is $1,320.79. The firm has a market cap of $23.02 billion, a PE ratio of 26.71, a price-to-earnings-growth ratio of 2.41 and a beta of 1.27.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The business had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. During the same quarter in the prior year, the company posted $8.19 EPS. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also
- Five stocks we like better than Mettler-Toledo International
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
